 | This article has not yet been rated on Wikipedia's content assessment scale. |
FDA woes
editNote: MelaFind is discussed in the book ``Innovation Breakdown by Joseph Gulfo. They had a lot of trouble getting FDA approval. Health economist Alex Tabarrok has reviewed the book (see [1] and [2]. I think it would be interesting to include a description of the difficulties the company had getting through the FDA. Danski14(talk) 13:20, 5 November 2021 (UTC)